Idera Pharmaceuticals, Inc. (IDRA) Reports In-Line Q3 Loss of 11c/Share
Tweet Send to a Friend
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q3 EPS of ($0.11) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
